PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 83 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $83 | -64.1% | 15,627 | -70.6% | 0.00% | -50.0% |
| Q4 2023 | $231 | -99.2% | 53,240 | +428.3% | 0.00% | – |
| Q1 2022 | $29,000 | -90.8% | 10,077 | -90.3% | 0.00% | -100.0% |
| Q4 2021 | $316,000 | -60.6% | 103,955 | -9.2% | 0.00% | -72.7% |
| Q3 2021 | $803,000 | +117.0% | 114,517 | +183.9% | 0.01% | +175.0% |
| Q2 2021 | $370,000 | -35.4% | 40,331 | -31.6% | 0.00% | -50.0% |
| Q1 2021 | $573,000 | +83.1% | 58,950 | +93.3% | 0.01% | +166.7% |
| Q4 2020 | $313,000 | -18.7% | 30,501 | -20.0% | 0.00% | -62.5% |
| Q3 2020 | $385,000 | +14.6% | 38,142 | +18.2% | 0.01% | -11.1% |
| Q2 2020 | $336,000 | -5.6% | 32,257 | -2.4% | 0.01% | -25.0% |
| Q3 2019 | $356,000 | – | 33,057 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $13,695,000 | 3.63% |
| BB BIOTECH AG | 576,991 | $38,081,000 | 1.81% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $375,320,000 | 0.97% |
| WEATHERBIE CAPITAL, LLC | 156,649 | $10,339,000 | 0.92% |
| Iguana Healthcare Management, LLC | 27,500 | $1,815,000 | 0.85% |
| DOHENY ASSET MANAGEMENT /CA | 22,630 | $1,494,000 | 0.71% |
| HealthCor Management, L.P. | 161,000 | $10,626,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 25,000 | $1,650,000 | 0.41% |
| Avalon Global Asset Management LLC | 7,500 | $495,000 | 0.30% |
| Avalon Global Asset Management LLC | 7,500 | $495,000 | 0.30% |